Peritoneum Glossary
BromAc: bromelain and acetylcysteine
CA 125: cancer antigen 125 (tumor marker blood test)
CA 19-9: cancer antigen 19-9 (tumor marker blood test)
CEA: carcinoembryonic antigen (tumor marker blood test)
CRS: cytoreductive surgery
DPAM: disseminated peritoneal adenomucinosis
EPIC: early postoperative intraperitoneal chemotherapy
FOLFIRI: chemotherapy regimen consisting folinic acid/leucovorin (FOL), Fluorouracil/5-FU (F), and irinotecan/Camptosar (IRI)
FOLFIRINOX: chemotherapy regimen consisting folinic acid/leucovorin (FOL), Fluorouracil/5-FU (F), irinotecan/Camptosar (IRI), and oxaliplatin/Eloxatin (OX)
FOLFOX: chemotherapy regimen consisting folinic acid/leucovorin (FOL), Fluorouracil/5-FU (F), and oxaliplatin/Eloxatin (OX)
GCC: goblet cell carcinoid
HAMN: high-grade appendiceal mucinous neoplasm
HIPEC: hyperthermic intraperitoneal chemotherapy
IPHC: intraperitoneal hyperthermic chemotherapy
LAMN: low-grade appendiceal mucinous neoplasm
MOAS: “mother of all surgeries;” a colloquial term to describe the CRS+HIPEC procedure
NED: no evidence of disease
NET: carcinoid (neuroendocrine) tumors arising from the neuroendocrine versus the epithelial cells of the appendix
PC: peritoneal carcinomatosis
PCI:peritoneal cancer index
PIPAC: pressurized intraperitoneal aerosolized chemotherapy
PMC/PMCA: peritoneal mucinous carcinomatosis
PMCA-I: peritoneal mucinous carcinomatosis-intermediate
PMP: pseudomyxoma peritonei
PSM: peritoneal surface malignancy
SRC: signet ring cell
TPN: total parenteral nutrition